Oropouche Virus Antibody (IgM)
Test Code
16766
86790
Clinical Significance
Oropouche Virus Antibody (IgM) - This immunoassay is intended for the qualitative detection of IgM antibodies to Oropouche virus in serum from patients suspected of having acute infection. A positive IgM result can help support diagnosis in a patient with the appropriate risk factors presenting with signs and symptoms consistent with Oropouche virus disease (Oropouche fever). If additional testing is needed, please contact the public health department.
Oropouche virus disease is a vector-borne infectious disease that is primarily transmitted through the bite of an infected midge or mosquito. The disease is found in South ...
Test Resources
Test Details
Methodology
Immunoassay (IA)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
Not Detected
Alternative Name(s)
Oropouche Fever,OROV
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria
Gross hemolysis • Lipemia • Icteric
Setup Schedule
1 mL serum
0.5 mL
Transport tube
Room temperature
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Gross hemolysis • Lipemia • Icteric